MX2014006538A - Novel amoebicidal compounds derived from ethyl and methyl quinoxaline-7-carboxylate 1,4-di-n-oxide. - Google Patents

Novel amoebicidal compounds derived from ethyl and methyl quinoxaline-7-carboxylate 1,4-di-n-oxide.

Info

Publication number
MX2014006538A
MX2014006538A MX2014006538A MX2014006538A MX2014006538A MX 2014006538 A MX2014006538 A MX 2014006538A MX 2014006538 A MX2014006538 A MX 2014006538A MX 2014006538 A MX2014006538 A MX 2014006538A MX 2014006538 A MX2014006538 A MX 2014006538A
Authority
MX
Mexico
Prior art keywords
ethyl
oxide
amoebicidal
carboxylate
novel
Prior art date
Application number
MX2014006538A
Other languages
Spanish (es)
Inventor
Gildardo Rivera Sánchez
Oscar Torres Ángeles
Original Assignee
Gildardo Rivera Sánchez
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gildardo Rivera Sánchez filed Critical Gildardo Rivera Sánchez
Priority to MX2014006538A priority Critical patent/MX2014006538A/en
Publication of MX2014006538A publication Critical patent/MX2014006538A/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention refers to derivatives of quinoxaline 1,4-di-N-oxide functionalized in the 7th position with groups derived from ethyl and methyl ester with excellent selectivity over Entamoeba histolytica and low toxicity. The present invention comprises the compounds described in the following general figure (see Formula), also comprising the pharmaceutically acceptable salts thereof and their use in drugs for treating humans and mammal animals with amebiasis.
MX2014006538A 2014-05-30 2014-05-30 Novel amoebicidal compounds derived from ethyl and methyl quinoxaline-7-carboxylate 1,4-di-n-oxide. MX2014006538A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX2014006538A MX2014006538A (en) 2014-05-30 2014-05-30 Novel amoebicidal compounds derived from ethyl and methyl quinoxaline-7-carboxylate 1,4-di-n-oxide.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2014006538A MX2014006538A (en) 2014-05-30 2014-05-30 Novel amoebicidal compounds derived from ethyl and methyl quinoxaline-7-carboxylate 1,4-di-n-oxide.

Publications (1)

Publication Number Publication Date
MX2014006538A true MX2014006538A (en) 2015-11-30

Family

ID=55400894

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014006538A MX2014006538A (en) 2014-05-30 2014-05-30 Novel amoebicidal compounds derived from ethyl and methyl quinoxaline-7-carboxylate 1,4-di-n-oxide.

Country Status (1)

Country Link
MX (1) MX2014006538A (en)

Similar Documents

Publication Publication Date Title
WO2015168466A8 (en) Inhibitors of lysine specific demethylase-1
EA201791420A1 (en) TRIAZOLOPYRIMIDIN COMPOUNDS AND THEIR APPLICATIONS
PH12016501813A1 (en) 1,3-benzodioxole derivative
GEP20186887B (en) Bicyclic-fused heteroaryl or aryl compounds and their use as irak4 inhibitors
TN2017000544A1 (en) 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as magl inhibitors
RS54873B1 (en) Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
WO2014152389A8 (en) Imaging agent for detection of diseased cells
PH12016501702B1 (en) Pyrazole amide derivative
MY192032A (en) Pharmaceutical composition with improved bioavailability
AR103680A1 (en) BACE1 SELECTIVE INHIBITORS
AU2018253590A1 (en) Imidazopyridazine compounds
PH12019501178A1 (en) Thiopene derivatives as antiviral agents
PH12017550004A1 (en) Heterocyclic derivatives and use thereof
CA2914620C (en) Heterocyclic derivatives and use thereof
JO3372B1 (en) 5-benzylisoquinoleine derivatives for the treatment of cardiovascular diseases
EA201791099A1 (en) QUINOLIN CARBOXAMIDE FOR USE IN THE TREATMENT OF LEUKEMIA
EA201790632A1 (en) 4'-VINYL-SUBSTITUTED DERIVATIVES OF NUCLEOSIDE AS A RNA REPLICATION INHIBITOR INHIBITOR WITH RESPIRATORY SYNCYTAL VIRUS
PH12016502568B1 (en) Novel heterocyclic compound
JOP20180071B1 (en) Use of aminoalkylbenzothiazepine derivatives
EA201990313A1 (en) DERIVATIVE TRIAZOLOPYRAZINONE USED AS A HUMAN PDE1 INHIBITOR
PH12016501645A1 (en) Aminopyrazolone derivative
MX2014006538A (en) Novel amoebicidal compounds derived from ethyl and methyl quinoxaline-7-carboxylate 1,4-di-n-oxide.
BR112016028081A2 (en) NEW COMPOUNDS AS ANTITUBERCULAR AGENTS
MX2016011310A (en) Endoparasite control agent.
EA201991141A1 (en) AMPLIFIERS BMP

Legal Events

Date Code Title Description
FG Grant or registration